Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.01
- Piotroski Score 4.00
- Grade Buy
- Symbol (EDAP)
- Company EDAP TMS S.A.
- Price $2.48
- Changes Percentage (-0.6%)
- Change -$0.02
- Day Low $2.41
- Day High $2.57
- Year High $8.50
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $19.00
- High Stock Price Target $19.00
- Low Stock Price Target $19.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.53
- Trailing P/E Ratio -9.91
- Forward P/E Ratio -9.91
- P/E Growth -9.91
- Net Income $-21,178,000
Income Statement
Quarterly
Annual
Latest News of EDAP
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
With 55% institutional ownership, Nedap N.V. (AMS:NEDAP) is a favorite amongst the big guns
In Nedap N.V. (AMS:NEDAP), institutions hold 55% ownership, making them the most influential shareholder group. Institutional ownership is seen as positive due to their resources and expertise. Top 5 ...
By Yahoo! Finance | 2 weeks ago -
Investing in Nedap (AMS:NEDAP) five years ago would have delivered you a 52% gain
Nedap N.V. (AMS:NEDAP) shareholders may be worried about the recent 10% drop in share price. However, over the last five years, the stock has shown a 21% increase, below the market's 74% return....
By Yahoo! Finance | 1 month ago -
EDAP TMS Shares Rise on Higher Revenue, Projected Growth
EDAP TMS shares surged on higher Q2 revenue and growth prospects. Despite a 16% increase, shares are still down 37% this year....
By MarketWatch | 2 months ago
